Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4367999

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Displacement of [3H]-5-CT from human 5HT7 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

5-hydroxytryptamine receptor 7 (CHEMBL3155)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT<sub>1A</sub> receptor ligands.
Ślifirski G, Król M, Kleps J, Podsadni P, Belka M, Bączek T, Siwek A, Stachowicz K, Szewczyk B, Nowak G, Bojarski A, Kozioł AE, Turło J, Herold F.
Eur J Med Chem (2019) 180 : 383 -397
PubMed 31325785 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
Ki 13 6.13 7.75

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL42 CLOZAPINE 4.0 1 7.75
CHEMBL4471755 1 6.26
CHEMBL4476164 1 5.96
CHEMBL4582567 1 5.95
CHEMBL4455658 1 5.87
CHEMBL4469633 1 5.86
CHEMBL4469537 1 5.77
CHEMBL4470437 1 5.61
CHEMBL715 OLANZAPINE 4.0 1 -
CHEMBL6437 MIANSERIN 4.0 1 -
CHEMBL54 HALOPERIDOL 4.0 1 -
CHEMBL53 APOMORPHINE 4.0 1 -
CHEMBL71 CHLORPROMAZINE 4.0 1 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL42 CLOZAPINE Ki = 18.0 nM 7.75
CHEMBL4471755 Ki = 546.0 nM 6.26
CHEMBL4476164 Ki = 1092.0 nM 5.96
CHEMBL4582567 Ki = 1112.0 nM 5.95
CHEMBL4455658 Ki = 1361.0 nM 5.87
CHEMBL4469633 Ki = 1384.0 nM 5.86
CHEMBL4469537 Ki = 1712.0 nM 5.77
CHEMBL4470437 Ki = 2431.0 nM 5.61
CHEMBL715 OLANZAPINE Ki - -
CHEMBL6437 MIANSERIN Ki - -
CHEMBL54 HALOPERIDOL Ki - -
CHEMBL53 APOMORPHINE Ki - -
CHEMBL71 CHLORPROMAZINE Ki - -